Orange Book product · Generic (ANDA)
LOXAPINE SUCCINATE
LOXAPINE SUCCINATE
At a glance
Sep 26, 2011
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Sep 26, 2011
14 yr 11 mo ago
Today
Pharmaceutical detail
Active ingredient
LOXAPINE SUCCINATE
Strength
EQ 5MG BASE
Dosage form
CAPSULE
Route
ORAL
TE code
AB
Application
ANDA 090695
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of LOXAPINE SUCCINATE
- —LOXITANEBrand (NDA)
NDA 017525 · TEVA BRANDED PHARM
- 2005LOXAPINE SUCCINATEGeneric (ANDA)
ANDA 076868 · ELITE LABS INC
- 2004LOXAPINE SUCCINATEGeneric (ANDA)
ANDA 076762 · RISING
- 1988LOXAPINE SUCCINATEGeneric (ANDA)
ANDA 072204 · WATSON LABS
- 1988LOXAPINE SUCCINATEGeneric (ANDA)
ANDA 072205 · WATSON LABS
- 1988LOXAPINE SUCCINATEGeneric (ANDA)
ANDA 072206 · WATSON LABS
- 1988LOXAPINE SUCCINATEGeneric (ANDA)
ANDA 072062 · WATSON LABS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
